Dimetacrine (brand names Istonil, Istonyl, Linostil, Miroistonil), also known as dimethacrine and acripramine, is a tricyclic antidepressant (TCA) used in Europe and formerly in Japan for the treatment of depression. It has imipramine-like effects; though, in a double-blind clinical trial against imipramine, dimetacrine was found to have lower efficacy in comparison and produced more weight loss and abnormal liver tests. Little is known about the pharmacology of dimetacrine, but it can be inferred that it acts in a similar manner to other TCAs. If this is indeed the case, dimetacrine may induce severe cardiac toxicity in overdose (a side effect unique to the tricyclic class of antidepressants).
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Dimetacrine (en)
- ジメタクリン (ja)
|
rdfs:comment
| - Dimetacrine (brand names Istonil, Istonyl, Linostil, Miroistonil), also known as dimethacrine and acripramine, is a tricyclic antidepressant (TCA) used in Europe and formerly in Japan for the treatment of depression. It has imipramine-like effects; though, in a double-blind clinical trial against imipramine, dimetacrine was found to have lower efficacy in comparison and produced more weight loss and abnormal liver tests. Little is known about the pharmacology of dimetacrine, but it can be inferred that it acts in a similar manner to other TCAs. If this is indeed the case, dimetacrine may induce severe cardiac toxicity in overdose (a side effect unique to the tricyclic class of antidepressants). (en)
- ジメタクリン(Dimetacrine)またはアクリプラミン(acripramine)は、ヨーロッパとかつての日本で、うつ病の治療に用いられていた三環系抗うつ薬である。イミプラミンと似た効果を持つが、イミプラミンに対する二重盲検法の臨床試験で、ジメタクリンの方が、効能が比較的弱く、体重減少と肝機能検査の異常数値が発生しやすくなる。薬理学についてはほとんど分かっていないが、他の三環系抗うつ薬と同様に作用すると推測されている。これが事実であれば、ジメタクリンを過量摂取すると心臓に対する深刻な毒性となる。 (ja)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
ATC suffix
| |
alt
| - Ball-and-stick model of the dimetacrine molecule (en)
- Skeletal formula of dimetacrine (en)
|
ATC prefix
| |
c
| |
CAS number
| |
ChemSpiderID
| |
DrugBank
| |
H
| |
image
| - Dimetacrine-3D-balls.png (en)
|
IUPAC name
| |
KEGG
| |
legal status
| |
n
| |
PubChem
| |
routes of administration
| |
SMILES
| |
title
| |
titlestyle
| |
tradename
| - Istonil, Istonyl, Linostil, Miroistonil (en)
|
UNII
| |
width
| |
has abstract
| - Dimetacrine (brand names Istonil, Istonyl, Linostil, Miroistonil), also known as dimethacrine and acripramine, is a tricyclic antidepressant (TCA) used in Europe and formerly in Japan for the treatment of depression. It has imipramine-like effects; though, in a double-blind clinical trial against imipramine, dimetacrine was found to have lower efficacy in comparison and produced more weight loss and abnormal liver tests. Little is known about the pharmacology of dimetacrine, but it can be inferred that it acts in a similar manner to other TCAs. If this is indeed the case, dimetacrine may induce severe cardiac toxicity in overdose (a side effect unique to the tricyclic class of antidepressants). (en)
- ジメタクリン(Dimetacrine)またはアクリプラミン(acripramine)は、ヨーロッパとかつての日本で、うつ病の治療に用いられていた三環系抗うつ薬である。イミプラミンと似た効果を持つが、イミプラミンに対する二重盲検法の臨床試験で、ジメタクリンの方が、効能が比較的弱く、体重減少と肝機能検査の異常数値が発生しやすくなる。薬理学についてはほとんど分かっていないが、他の三環系抗うつ薬と同様に作用すると推測されている。これが事実であれば、ジメタクリンを過量摂取すると心臓に対する深刻な毒性となる。 (ja)
|
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
alternative name
| - Istonil, Istonyl, Linostil, Miroistonil (en)
|
CAS number
| |
DrugBank
| |
FDA UNII code
| |
KEGG
| |
PubChem
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |